Altamira Therapeutics: Funding, Investors & Team (Sep 2026)
Altamira Therapeutics is committed to creating innovative drugs to preserve hearing, alleviate tinnitus, and improve balance. They are at the forefront of developing treatments for inner ear disorders in the field of neurotology.
Altamira Therapeutics has raised $4.0M across 1 funding round on record, the most recent an undisclosed round of $4.0M announced in Sep 2024.
That round is below the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
Altamira Therapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2024.
Altamira Therapeutics Funding Rounds
Altamira Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Altamira Therapeutics Funding Compared to Other Health Care Startups
Altamira Therapeutics' latest round of $4.0M is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Altamira Therapeutics in Health Care and Basel
Companies Similar to Altamira Therapeutics
MoleSense is to provide a wearable skin sensor to help monitor high-risk pregnancies.
CeQur Simplicity helps people with diabetes by developing drug-delivery devices. They develop bolus insulin…
Calmea develops advanced contactless sensing systems that invisibly track sleep and automatically modify…
NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for…
UNBOOUND is a medtech company and university spin-off (The Rockefeller University and University of Geneva)…
Christina Vallgren and Marcus Palm, two physicists from CERN, co-founded Terapet along with Professor Raymond…
Axmed is a company that specializes in serving low and middle-income countries (LMICs), with the goal of…
Babylat is an enricher device is the first automated, small-scale tabletop device for the protein enrichment…
Altiscreen is creating and producing cutting-edge, portable drug-of-abuse detection systems. With the use of…
Vivent provides growers, breeders and agrochem companies with actionable information direct from plants…
Multiwave develops breakthrough Magnetic Resonance Imaging and Positron Emission Tomography devices. Founded…
Altamira Therapeutics Funding FAQs
What does Altamira Therapeutics do?
Altamira Therapeutics is committed to creating innovative drugs to preserve hearing, alleviate tinnitus, and improve balance. They are at the forefront of developing treatments for inner ear disorders in the field of neurotology.
How much funding has Altamira Therapeutics raised?
Altamira Therapeutics has raised $4.0M across 1 round on record. The most recent is an undisclosed round of $4.0M announced in Sep 2024.
When did Altamira Therapeutics last raise funding?
Altamira Therapeutics' most recent funding round on record is an undisclosed round of $4.0M, announced in Sep 2024.
Who founded Altamira Therapeutics?
FundedIQ lists Thomas Meyer (Founder) at Altamira Therapeutics.
Where is Altamira Therapeutics headquartered?
Altamira Therapeutics is based in Basel, Basel-Stadt, Switzerland.
How many employees does Altamira Therapeutics have?
Altamira Therapeutics is in the 11-50 employee band.
How does Altamira Therapeutics' funding compare to other Health Care startups?
Altamira Therapeutics' latest round of $4.0M is below the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Altamira Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Altamira Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.